Aizawa's v66v ³¤³°IP News&Tips

²þÀµ¤Î¿¤¤³¤³°Ãκâ¾ðÊó¡¢È÷˺ϿŪ¤ËÃΤäƤ뤳¤È¤À¤±ÆÈ¤ê¸À¡ª

ȽÎ㸦µæ

[ ¥ê¥¹¥È | ¾ÜºÙ ]

µ­»ö¸¡º÷
¸¡º÷

Á´4¥Ú¡¼¥¸

[1] [2] [3] [4]

[ ¼¡¤Î¥Ú¡¼¥¸ ]

²¤½£¶¦Æ±Âξ¦É¸°Õ¾¢Ä£¡ÊOHIM)¿³È½Éô¤Ï¥·¥å¥ì¥Ã¥À¡¼¤Î¥«¥Ã¥¿¡¼»õ¤Ë´Ø¤¹¤ëÅÐÏ¿°Õ¾¢253778-0001¤òµ¡Ç½À­¤ÎÍýͳ¤Ë´ð¤Å¤¯Ìµ¸ú¤ÎȽÃǤò½é¤á¤Æ¤Î²¼¤·¤¿¡£¡Ê22 October 2009, R 690/2007-3)

¥·¥å¥ì¥Ã¥À¡¼¼«ÂΤϤ´¤ß¤Î¤ò´Þ¤á¤¿½èÍý¤¬¤Ç¤­¤ë¤â¤Î¤Ç¡¢¥«¥Ã¥¿¡¼»õ¼«ÂΤÏÈæ³ÓŪ¸«¤¨¤Ê¤¤¤¿¤á¤ËÊݸî¤ÎÍ×·ï¤Ç¤¢¤ë4¾ò(2)(a)¹à¤òËþ¤¿¤µ¤Ê¤¤¤È»×¤ï¤ì¤¿¤¬¡¢Á´ÂΤ¬»ÈÍÑÃæ¤Î°ì»þŪ¤Ë¤Ç¤â¸«¤¨¤ëÍýͳ¤«¤é¡¢¿³È½Éô¤Ïµ¡Ç½À­¤ÎÉôʬ¤ËÃåÌܤ·¤¿¡£¤Ä¤Þ¤ê¡¢°Õ¾¢¼«ÂΤ¬À½Éʤε»½ÑŪ¤ÊÍ×ÁǤ˴ð¤Å¤­¤Ê¤µ¤ì¤Æ¤¤¤ë¤â¤Î¤«¤É¤¦¤«¤ò8¾ò(1)¹à¤ÇȽÃǤ·¤¿¡£°Õ¾¢À߷פȤ·¤ÆÁϺî¼Ô¤¬£²¤Ä¤«¤½¤ì°Ê¾å¤Î¾¤ÎÁªÂò»è¤¬¤¢¤ë¤â¤Î¤Ç¤¢¤ì¤Ðµ¡Ç½Åª¤È¤Ï¸À¤¨¤Ê¤¤¡£ËÜ·ï¤Ç¤ÏÁªÂò»è¤¬¸Â¤é¤ì¤¿¤È¸«¤é¤ì¡¢µ»½ÑŪµ¡Ç½¤Ë¤è¤ë¤ÈȽÃǤµ¤ì¡¢25¾ò1(b)¹à¤Î̵¸úÍýͳ¤ËÅö¤¿¤ë¤ÈȽÃǤµ¤ì¤¿¡£

Âè8¾ò µ»½ÑŪµ¡Ç½¤Ë¤è¤Ã¤Æ·èÄêÉÕ¤±¤é¤ì¤ë°Õ¾¢µÚ¤ÓÁê¸ßÏ¢·ë¤Î°Õ¾¢
(1) ¶¦Æ±Âΰվ¢¤Ï¡¤Àì¤éµ»½ÑŪµ¡Ç½¤Ë¤è¤Ã¤Æ·èÄêÉÕ¤±¤é¤ì¤ëÀ½Éʳ°´Ñ¤ÎÆÃħ¤Ë¤Ï¸ºß¤·¤Ê¤¤¤â¤Î¤È¤¹¤ë¡£
(2) ¶¦Æ±Âΰվ¢¤Ï¡¤À½Éʳ°´Ñ¤ÎÆÃħ¤Ç¤¢¤Ã¤Æ¡¤¤½¤Î°Õ¾¢¤¬ÁȤ߹þ¤Þ¤ì¤Æ¤¤¤ë¤«Ëô¤ÏŬÍѤµ¤ì¤Æ¤¤¤ëÀ½Éʤò¾¤ÎÀ½Éʤ˵¡³£Åª¤ËÏ¢·ë¤¹¤ë¤«Ëô¤Ï¾¤ÎÀ½ÉʤÎÃæ¡¤¼þ°Ï¼ã¤·¤¯¤Ï¤½¤ì¤ËÀܤ·¤ÆÀßÃÖ¤¹¤ë¤³¤È¤Ë¤è¤ê¡¤²¿¤ì¤ÎÀ½Éʤ⤽¤Îµ¡Ç½¤ò²Ì¤¿¤¹¤³¤È¤¬¤Ç¤­¤ë¤è¤¦¤Ë¤¹¤ë¤¿¤á¤Ë¡¤É¬Á³Åª¤ËÀµ³Î¤Ê·Á¾õµÚ¤ÓÀ£Ë¡¤ÇºÆ¸½¤·¤Ê¤±¤ì¤Ð¤Ê¤é¤Ê¤¤¤â¤Î¤Ë¤Ï¸ºß¤·¤Ê¤¤¤â¤Î¤È¤¹¤ë¡£
(3) (2)¤Ë¹´¤é¤º¡¤¶¦Æ±Âΰվ¢¤Ï¡¤¥â¥¸¥å¡¼¥ë¡¦¥·¥¹¥Æ¥à¤Ë¤ª¤¤¤Æ¡¤Áê¸ß¤Ë¸ò´¹²Äǽ¤ÊÀ½ÉʤÎÊ£¹çŪÁÈΩËô¤ÏÏ¢·ë¤ò²Äǽ¤Ë¤¹¤ëÌÜŪ¤Ë¤«¤Ê¤¦°Õ¾¢¤Ë¤Ï¡¤Âè5¾òµÚ¤ÓÂè6¾ò¤Ëµ¬Äꤷ¤¿¾ò·ï¤Î²¼¤Ç¡¤Â¸ºß¤¹¤ë¤â¤Î¤È¤¹¤ë¡£
JPO¤è¤ê

OHIM¤Ë¤è¤ë¤È¡¢ºÇ½é¤Î²¤½£ºÛȽ½ê¡ÊECJ¡Ë¤Ë¤è¤ëFundación Española para la Innovación de la Artesanía (FEIA¡Ë¤ÈCul de Sac Espacio Creativo SL; Acierta Product & Position SA,¤Î¶¦Æ±Âΰվ¢»ö·ï¡ÊC-32/08¡Ë¤¬2009ǯ7·î2¤Ë¸À¤¤ÅϤµ¤ì¤¿¡£ECJ¤ËÉÕÂ÷¤µ¤ì¤¿ÅÀ¤Ï¡¢¥³¥ß¥Ã¥·¥ç¥ó¥Ù¡¼¥¹¤Ë¤è¤êºîÀ®¤µ¤ì¤¿ÈóÅÐÏ¿¶¦Æ±Âΰվ¢¸¢¤Îµ¢Â°¤Ë´Ø¤·¡¢¶¦Æ±Âΰվ¢Ë¡14¾ò3¹à¤Îµ¬Ä꤬¤½¤ÎÂоݤǤ¢¤ë¡£

°Õ¾¢Ë¡14¾ò1¹à¤Îµ¬Äê¤Ç¤Ï°Õ¾¢¤ÎÁϺî¤Ï¡¢·ÀÌó¤Ë¤è¤ëÆÃÃʤθ¢Íø¼Ô¤¬¤Ê¤±¤ì¤Ð¡¢ÁϺî¼Ô(¥Ç¥¶¥¤¥Ê¡¼)¤Ëµ¢Â°¤¹¤ë¤È²ò¼á¤µ¤ì¤Æ¤¤¤ë¡£ËÜ·ï¤Ï¡¢¥³¥ß¥Ã¥·¥ç¥ó¥Ù¡¼¥¹¤ËºîÀ®¤µ¤ì¤¿ÈóÅÐÏ¿¶¦Æ±Âΰվ¢¤Ç¤¢¤ê¡¢Åö»ö¼Ô¤Ï¸ÛÍÑ·ÀÌó¤ÎÆâÍÆ¤Ë´ð¤Å¤­³«È¯¤µ¤ì¤¿°Õ¾¢¤È¤ÏƱ¤¸¤È¹Í¤¨¤é¤ì¤Æ¤¤¤Ê¤¤ÅÀ¡¢¤½¤·¤ÆÌÀ³Î¤Ê·ÀÌó¤ËÌ뵬Ä꤬¤Ê¤¤¤³¤È¤¬¥Ý¥¤¥ó¥È¤Ç¤¢¤ë¡£

°ìÊý¡¢°Õ¾¢Ë¡14¾ò3¹à¤Ï¡¢¸ÛÍѾå¤ÎÈï¸ÛÍѼԤεÁ̳¼ã¤·¤¯¤Ï¸ÛÍѼԤλؼ¨¤Ë¤è¤ê³«È¯¤·¤¿°Õ¾¢¤Îµ¢Â°¤òµ¬Äꤷ¤Æ¤ª¤ê¡¢ÆÃ¤ËƱ°Õ¤¬¤Ê¤¤¾ì¹ç¡¢¤Þ¤¿Åö³º¹ñ¤Ç¤Î¹ñÆâË¡¤ËÆÃÊ̤ε¬Äø¤¬¤Ê¤¤¾ì¹ç¤ò¾ò·ï¤È¤·¤Æ¤¤¤ë¡£¤Ä¤Þ¤ê¡¢¤³¤Î£²¤Ä¤ÎÎã³°¤òµ¬Äꤷ¤Æ¤ª¤ê¡¢Á°¼Ô¤Ï¸ÛÍÑ·ÀÌó¤Ë¤É¤Î¤è¤¦¤Êµ¬Ä꤬¤¢¤ë¤«¤Ë¤è¤ê¸ÛÍѼԤ˵¢Â°¤¬·è¤Þ¤ë¡£¸å¼Ô¤Ï¹ñÆâË¡¤Ç¸ÛÍÑ·ÀÌó¤ÎÆâÍÆ¤Ë¤è¤é¤º¡¢°Õ¾¢¤Îµ¢Â°¤òÁϺî¼Ô¤È¤·¤Æ¤¤¤ë¤«¤É¤¦¤«¤Ç¤¢¤ë¡£

¤¤¤º¤ì¤Ë¤·¤Æ¤â¡¢ËÜ·ï¤ÇECJ¤Ï3¹à¤Îµ¬Äê¤ÏŬÍѤµ¤ì¤º¡¢1¹à¤Ë¤è¤ê¡¢ÌÀ¼¨¤Î·ÀÌó¾ò¹à¤¬¤Ê¤¤¤³¤È¤òÍýͳ¤Ëµ¢Â°Àè¤òÁϺî¼Ô¤È¤¹¤ë¤Ù¤­¤Ç¤¢¤ë¤ÈȽ¤¸¤Æ¤¤¤ë¡£

¤³¤¦¤·¤¿°ÑÂ÷À½Â¤¤ä³«È¯¤Ë¤ª¤±¤ëȯÌÀ¤ä°Õ¾¢¤Ë´Ø¤¹¤ë¼è°·¤¤¤¬Û£Ëæ¤Ê·ÀÌó½ñ¤òÎɤ¯Ìܤˤ¹¤ë¡£¤³¤ì¤ÏÈñÍÑÉéô¤ËÌܤ¬Ã¥¤ï¤ì¤Æ¡¢À®²Ìʪ¤Ë¤Ä¤¤¤Æ¤ÎÃÎŪºâ»º½Ð´ê¸¢¡¢ÅÐÏ¿¸å¤Î¸¢Íø°Ý»ý¤ä»ÈÍѸ¢¤Ê¤É¤Ë¤Ä¤¤¤Æ¤Þ¤Ã¤¿¤¯¹Í¤¨¤Æ¤¤¤Ê¤¤¤³¤È¤¬¤¢¤ë¡£ËÜ·ï¤ÏÈóÅÐÏ¿°Õ¾¢·ï¤È¤¤¤¦ÆÃ¼ìÀ­¤â¤¢¤ë¤¬¡¢·ÀÌó½ñ¤Î¾ò¹à¤Ï½ÅÍפǤ¢¤ë¡£¤Þ¤¿¡¢³Æ¹ñÆâË¡¤Ë¤Ä¤¤¤Æ¤Ï¤½¤ÎÃϰè¤ÎÊÛ¸î»Î°Õ¸«¤ò¼èÆÀ¤¹¤ëɬÍפ¬¤¢¤ë¡£

¡Ê»²¹ÍȽÎã¡§Case 327/82 Ekro [1984] ECR 107, paragraph 11; Case C ‑ 287/98 Linster [2000] ECR I-6917, paragraph 43; and Case C ‑ 316/05 Nokia [2006] ECR I-12083, paragraph 21).

http://oami.europa.eu/ows/rw/resource/documents/CTM/case-law/jj080032_en.pdf

¥Õ¥é¥ó¥¹ºÇ¹â¹ÔÀ¯ºÛȽ½ê¤Ï2009ǯ3·î31ÆüSAS Foli vs SA Morgan»ö·ï¤Ë¤ª¤¤¤Æ¡¢¶¦Â¸·ÀÌó°ãÈ¿¤Ï¿¯³²¤ò¹½À®¤¹¤ë¤È¤ÎȽÃǤò¼¨¤·¤¿¡£ËÜ·ï¤Ç¤Ï°ìÊý¤ÎÅö»ö¼Ô¤¬¾ï¤Ë¾¦É¸¤òH Morgan international¤ËÆÃÄê¤Î¿Þ·Á¤òÉÕ¤±¤Æ»ÈÍѤ¹¤ë¤³¤È¤ò¾µÇ§¤·¤Æ¤¤¤¿¤¬¡¢¤½¤Î¥é¥¤¥»¥ó¥·¡¼¤¬¤½¤ÎµÁ̳¤ò½½Ê¬¤ËÍú¹Ô¤·¤Æ¤¤¤Ê¤«¤Ã¤¿¡£

ºÇ¹â¹ÔÀ¯ºÛȽ½ê¤Ï¶¦Â¸·ÀÌó¤Ï¸·³Ê¤ËŬÍѤµ¤ì¤ë¤Ù¤­¤Ç¤¢¤ë¤È¤³¤È¤ò³Îǧ¤·¡¢¤½¤Î¤è¤¦¤Ê»ö¼Â¤¬¤¢¤ì¤Ð¡¢¤â¤¦°ìÊý¤ÎÅö»ö¼Ô¤Î¾¦É¸¸¢¤òÅö³º¥é¥¤¥»¥ó¥·¡¼¤¬¿¯³²¤·¤Æ¤¤¤ë¤È¸«Ðö¤µ¤ì¤ë¤È¤È¤·¤¿¡£

NL Brevalex

ÆÃµöË¡±¡¤Ï¡¢2009ǯ6·î5ÆüÉÕ2009¥Û1736Ƚ·è¤Ë¤ª¤¤¤Æ¡¢·ÈÂÓÅÅÏäμýǼȢ¤ÎÅÐÏ¿¥Ç¥¶¥¤¥ó¤Î̵¸ú¿³È½»ö·ï¤Ë¤ª¤¤¤Æ¡¢ÅÐÏ¿¥Ç¥¶¥¤¥ó¤Î¿ÞÌ̤˻²¹Í¿Þ¤ò´Þ¤à¾ì¹ç¡¢¡Ö¥Ç¥¶¥¤¥ó¤ÎÀâÌÀ¡×Íó¤Ë½Ð´êÂоݥǥ¶¥¤¥ó¤Î·ÁÂÖ¤ÈÌÀ¼¨¤µ¤ì¤Æ¤¤¤ëÅù¤ÎÆÃÊ̤ʻö¾ð¤¬¤Ê¤¤¸Â¤ê¡¢¸¶Â§Åª¤Ë¥Ç¥¶¥¤¥ó¤Î·ÁÂÖ¤òÊä½¼¤¹¤ë¤â¤Î¤Ç¤¢¤Ã¤Æ¿·¤¿¤Ê¥Ç¥¶¥¤¥ó¤Î·ÁÂÖ¤ò¿Þ¼¨¤¹¤ë¤â¤Î¤Ç¤Ï¤Ê¤¤¡£ËÜÅÐÏ¿¥Ç¥¶¥¤¥ó¤Ç¤ÏÊѲ½Á°¸å¤Î·Á¾õ¡¦ÌÏÍͤòɽ¸½¤¹¤ë¿ÞÌ̤¬½½Ê¬¤Ë²Ã¤¨¤é¤ì¤Æ¤ª¤é¤º¡¢¤Þ¤¿¡Ö»²¹Í¿Þ£±¤ÏËÜ´ê¥Ç¥¶¥¤¥óÆâÉô¤Î³¸¤òʬΥ¤·¤¿¾õÂ֡פȵ­ºÜ¤·¤ÆÆâÉô¤Î³¸¤¬Ê¬Î¥¤µ¤ì¤Æ¤¤¤Ê¤¤¤â¤Î¤À¤±¤¬ËÜ´ê¥Ç¥¶¥¤¥ó¤Ç¤¢¤ë¤ÈÀâÌÀ¤·¤Æ¤¤¤ë¤Î¤¬ÌÀ¤é¤«¤Ç¤¢¤ë¤Î¤Ç¡¢¾å¤Î»²¹Í¿Þ£±¤ÏÅÐÏ¿¥Ç¥¶¥¤¥ó¤ò¹½À®¤¹¤ë¿ÞÌ̤ǤϤʤ¯¡¢½¾¤Ã¤Æ¤³¤ì¤ò½ü¤¤¤ÆÈæ³Ó¤·¤Æ¤ß¤ë¤Èξ¥Ç¥¶¥¤¥ó¤ÏÎà»÷¤·ÅÐÏ¿¥Ç¥¶¥¤¥ó¤Ï̵¸ú¤Ç¤¢¤ë¤ÈȽ¼¨¤·¤¿¡£

´Ú¹ñ¥Ç¥¶¥¤¥óÊݸîË¡¤Ç¤Ï¡¢ÅÐÏ¿¥Ç¥¶¥¤¥ó¤ÎÊݸîÈϰϤϭ¡½Ð´ê½ñ¤Îµ­ºÜ»ö¹à¡¢­¢¿ÞÌ̡ʼ̿¿¤Þ¤¿¤Ï¸«Ëܡˡ¢¤ª¤è¤Ó­£¿ÞÌ̤˵­ºÜ¤µ¤ì¤¿¥Ç¥¶¥¤¥ó¤ÎÀâÌÀ¤Ë¤è¤Ã¤ÆÄê¤á¤é¤ì¤ë¤Èµ¬Äꤵ¤ì¡ÊƱˡÂè43¾ò¡Ë¡¢¼Ð»ë¿Þ¤ª¤è¤ÓÏ»Ì̿ޤμ·¤Ä¤Î¿ÞÌ̤Ïɬ¤ºÄó½Ð¤·¤Ê¤±¤ì¤Ð¤Ê¤é¤Ê¤¤¡Ê»Ü¹Ôµ¬Â§Âè5¾ò¡Ë¡£¿ÞÌ̤ΤߤǤÏʪÉʤòÍý²ò¤·¤Å¤é¤¤¾ì¹ç¡¢¤Þ¤¿¤ÏʪÉʤε¡Ç½¤«¤éÊѲ½¤¹¤ë·Á¾õ¤Ê¤É¤òÅÐÏ¿¤¹¤ë¾ì¹ç¤Ë¤Ï¡¢¤½¤ÎÀâÌÀ¤òµ­ºÜ¤¹¤ë¤è¤¦¤Ëµ¬Äꤵ¤ì¤Æ¤¤¤ë¡Ê»Ü¹Ôµ¬Â§Âè7¾ò¡Ë¡£

ËÜÅÐÏ¿¥Ç¥¶¥¤¥ó¤Ç¤Ï¡¢¼Ð»ë¿Þ¡¢Ï»Ì̿ޤª¤è¤Ó»²¹Í¿Þ£±¤òÄó½Ð¤µ¤ì¡¢¥Ç¥¶¥¤¥ó¤ÎÀâÌÀ¤Ë¤Ï¡ÖËÜ´ê¥Ç¥¶¥¤¥ó¤Ï·ÈÂÓÅÅÏ䪤è¤Ó¤³¤ÎÉÕ°Éʤò°ÂÁ´¤ËήÄ̤µ¤»¤ë¤¿¤á¤Î¤â¤Î¤Ç¤¢¤ë/»²¹Í¿Þ£±¤ÏËÜ´ê¥Ç¥¶¥¤¥óÆâÉô¤Î³¸¤òʬΥ¤·¤¿¾õÂ֤Ǥ¢¤ë¡×¤Èµ­ºÜ¤µ¤ì¤Æ¤¤¤ë¡£

ËÜ·ï¤ÏÂçË¡±¡¤Ë¾å¹ðÃæ¤Ç¤¢¤ë¤Î¤ÇÆÃµöË¡±¡È½·è¤ËÂФ¹¤ëÂçË¡±¡¤ÎȽÃǤ¬ÃíÌܤµ¤ì¤ë¡£

¤È¤³¤í¤Ç¡¢Ãæ¹ñ¤Ç¤âƱ¼ï¤ÎȽ·è¤¬¤¢¤ë¤Î¤Ç¡¢ÀâÌÀ½ñ¤Îµ­ºÜ¡¢¤Þ¤¿»ÈÍѾõÂ֤䟳«¿Þ¤ò»²¹Í¿Þ¤È¤»¤º¤Ë¿ÞÌ̤ΰìÉô¤Ë¤¹¤ë¡¢¤Þ¤¿Ê̽дê¤ò¤¹¤ë¤Ê¤É¤ÎÂбþ¤¬É¬Íפȹͤ¨¤ë¡£

²¤½£ºÛȽ½ê¡ÊECJ)¤Ï¡¢Wellcome Foundation v Paranova Pharmazeutica Handels»ö·ï¡ÊC-276/05¡Ë¤Ë¤ª¤¤¤Æ¡¢¥ª¡¼¥¹¥È¥ê¥¢ºÛȽ½ê¤ËÂФ·¡¢Ê¹ÔÍ¢Æþ°åÌôÉʤκÆÊñÁõ(repackaging¡Ë¤Ë´Ø¤¹¤ë»Ø¿Ë¤ò½Ð¤¹¤³¤È¤òµá¤á¤¿¡£¤³¤ÎºÆÊñÁõºî¶È¤Ï¾¦Éʤμ«Í³¤Ê°Üư¤Ë´Ø¤¹¤ë²¤½£Ë¡¤äEU°èÆâ¤Î°Û¤Ê¤ëÃϰè¤ÇƱ°ì¥Ö¥é¥ó¥É¤Î¾¦Éʤξ®Çä²Á³Ê¤òÊѤ¨¤ë¤³¤È¤ÇÍø±×¤ò¤¢¤²¤ëÍ¢Æþ¶È¼Ô¤Ë¤ÏÍ­Íø¤Ê¤â¤Î¤Ç¤¢¤ë¡£ËÜ·ï¤Ï¡¢Ê¿¹ÔÍ¢Æþ¶È¼Ô¤¬Àµµ¬ÉʤòºÆÊñÁõ¤¹¤ë¾ì¹ç¤Ë¤É¤ÎÄøÅÙ¤ÎÄÌÃΤò¾¦É¸¸¢¼Ô¤Ë¤¹¤ë¤Ù¤­¤«¤òÌ䤦½ÅÍפÊÌäÂê¤Ç¡¢ËÜ·èÄê¤ÏºÆÊñÁõºî¶È¤ËÂФ¹¤ë¾¦É¸¸¢¼Ô¤Î¸Â¤é¤ì¤¿¸¢¸Â¤ÎºÆ¹Ô»È¤Ë´Ø¤¹¤ë¤â¤Î¤Ç¤¢¤ë¡£

ECJ¤Î´ûȽ·è¤ÎBristol Meyers Squibb v Paranova(C-427/93)¤Ë¤ª¤¤¤Æ½å¼é¤¹¤ë¤Ù¤­°Ê²¼¤Î£µ¤Ä¤Î»Ø¿Ë¤¬Äê¤á¤é¤ì¤Æ¤¤¤ë

1. ¤½¤ÎºÆÊñÁõ¤¬ÉԲķç¤Ç¤¢¤ë¡£
2. ºÆÊñÁõ¤Ç¤Ï¤½¤ÎÀ½Éʤθ¶Êª¤Î¾õÂÖ¤òÊѹ¹¤·¤Æ¤Ï¤Ê¤é¤Ê¤¤¡£
3. ºÆÊñÁõ¤Ç¤Ï¡¢ºÆÊñÁõ¼Ô̾¡¢¸µ¤ÎÀ½Â¤¼Ô̾¤òÌÀµ­¤·¤Ê¤±¤ì¤Ð¤Ê¤é¤Ê¤¤¡£
4. ºÆÊñÁõ¤¬¾¦É¸¸¢¼Ô¤ÎɾȽ¤ò»³²¤¦¤â¤Î¤Ç¤¢¤Ã¤Æ¤Ï¤Ê¤é¤Ê¤¤¡£
5. ºÆÊñÁõ¼Ô¤ÏÈÎÇ䳫»ÏÁ°¤Ë¾¦É¸¸¢¼Ô¤ËÄÌÃΤ·¡¢Í×ÀÁ¤Ë±þ¤¸¸«ËܤòÄ󶡤·¤Ê¤±¤ì¤Ð¤Ê¤é¤Ê¤¤¡£

»ö·ï³µÍפϡ¢Paranova¤¬Wellcome¤¬¥®¥ê¥·¥ã¤ÇÈÎÇ䤷¤¿Àµµ¬ÉÊZOVIRAX¤ò¥ª¡¼¥¹¥È¥ê¥¢¤ÇÈÎÇ䤹¤ë¤¿¤á¤ËºÆÊñÁõ¤·ÈÎÇä¤ò³«»Ï¤·¤¿¡£Wellcome¤Ï¥¦¥£¡¼¥ó¾¦»öºÛȽ½ê¤ËParanova¤ÎºÆÊñÁõÀ½ÉʤÎÍ¢Æþ²¾º¹»ß¤ÎÀÁµá¤ò¹Ô¤Ã¤¿¡£

Paranova¤Ï¡¢¥ª¡¼¥¹¥È¥ê¥¢¤Ç¤Ï¥®¥ê¥·¥ã¤ÇÈÎÇ䤵¤ì¤ë70¾û¤è¤ê10¾û¾¯¤Ê¤¤60¾û¤¬ÈÎÇ䤵¤ì¤ëºÇÂç¿ôÎ̤Ǥ¢¤ê¡¢ºÆÊñÁõ¤¬É¬ÍפǤ¢¤ë¤³¤È¡¢¾ûºÞ¤ò¥Ö¥ê¥¹¥¿¡¼¡ÊÆ©ÌÀ¤Ë¤Õ¤¯¤ì¤¿¥×¥é¥¹¥Á¥Ã¥¯¡ËÊñÁõ¤«¤é¼è¤ê½Ð¤·¤Æ¤¤¤Ê¤¤¤³¤È¡¢¸µ¤ÎÀ½Â¤¼Ô̾¤âºÆÊñÁõ¼Ô̾¤âɽ¼¨¤·¤Æ¤¤¤ë¤³¤ÈWellcome¤ËÂФ·¤Æ·ÐºÑŪÍýͳ¤«¤éÈÎÇ䥵¥ó¥×¥ë¤ÎÄ󶡤äÍ¢½Ð¸µ¤Î¾ðÊó¤Î³«¼¨¤òµñ¤ó¤Ç¤¤¤¿¤³¤È¤òÀâÌÀ¤·¤¿¡£

Wellocome¤ÏºÆÊñÁõ¼Ô̾¤¬¾¦É¸¸¢¼Ô̾¤è¤êÂ礭¤¯É½¼¨¤µ¤ì¤Æ¤ª¤êÉÔ½½Ê¬¤Ç¤¢¤ë¤³¤È¡¢Îà»÷¤¹¤ëÀĤ¤Àþ¾õ¤Î¾¦É¸¤òÉÕ¤·¤Æ¤¤¤ë¤¬¡¢¤½¤Î»ÈÍѤϼ«¼Ò¤Î¥Ö¥é¥ó¥É²½¤Ë¤ª¤¤¤Æ¼õ¤±¤Æ¤¤¤ëɾȽ¤ò»¤Ê¤¦¤â¤Î¤Ç¤¢¤ë¤³¤È¡¢¤µ¤é¤ËÈÎÇ䥵¥ó¥×¥ë¤ÎÄ󶡤äÍ¢½Ð¸µ¤Î¾ðÊó¤¬Ä󶡤µ¤ì¤Æ¤¤¤Ê¤¤¤³¤È¤òÏÀÅÀ¤È¤·¤Æ¾å¤²¤¿¡£

ºÛȽ½ê¤ÏÀÁµá¤Î°ìÉô¤òǧ¤á¤ì¤¿¤¬¡¢Â裴¤È£µ¤Î¥Ý¥¤¥ó¥È¤ÎÌÀ³Î¤Ê²ò¼á¤òECJ¤Ëµá¤á¤¿¡£

ECJ¤Ï¡¢ÊñÁõ¤Îɽ¼¨¤¬ÀµÅö¤Ç¤¢¤ë¤«¤É¤¦¤«¤ÎȽÃǤϡ¢¤½¤Îɽ¼¨¤¬¾¦É¸¤â¤·¤¯¤Ï¾¦É¸¸¢¼Ô¤Î̾À¼¤ò»¤Ê¤¦ÄøÅ٤Τâ¤Î¤«¤Î¹Í»¡¤Ë´ð¤¯¤Ù¤­¤Ç¤¢¤ê(para30)¡¢¤½¤Î±Æ¶Á¤¬¾¦É¸¤ËÂФ·¤Æ²Äǽ¤Ê¸Â¤ê¾®¤µ¤¤¤â¤Î¤Ç¤¢¤ë¤È¤ÎȽÃÇ´ð½à¤Ë´ð¤¯¤Ù¤­¤Ç¤Ê¤¤(para.27)¡£¤³¤ì¤ËºÛȽ½ê¤ÎȽÃǤÏ˸¤²¤Ê¤¤¡£¤Þ¤¿¡¢Ê¹ÔÍ¢Æþ¼Ô¤Ï¾¦É¸¸¢¼Ô¤¬¤½¤ÎºÆÊñÁõ¤¬É¬ÍפǤ¢¤ë¤«¤É¤¦¤«¤òȽÃǤǤ­¤ëÁ´¤Æ¤Î¾ðÊó¤ÎÄ󶡤ò¤·¤Ê¤±¤ì¤Ð¤Ê¤é¤º¡¢¤³¤ì¤ËÍ¢Æþ¹ñ¤Î¾ðÊ󤬾õ¶·¤Ë¤è¤ê´Þ¤Þ¤ì¤Æ¤âÎɤ¤¤ÈȽ¤¸¤¿¡£

Í¢Æþ¶È¼Ô¤Ë²Ý¤»¤é¤ì¤ë¾¦É¸¸¢¼Ô¤Î¤¿¤á¤Îɽ¼¨Í×·ï¤ÏÊѤï¤é¤Ê¤¤¡¢¤Þ¤¿¾¦Éʤμ«Í³¤Ê°Üư¤Ë´Ø¤¹¤ëEUË¡¾å¤ÎÈæ³ÓŪ¿ÊÊâŪ¤Êµ¬Äê¤Ë¤â¤«¤«¤ï¤é¤º¾¦É¸¸¢¼Ô¤Ë¤Ï¼«¼ÒÀ½ÉʤËÂФ¹¤ëɽ¼¨¤Î°ì´ÓÀ­¤Ë¤Ä¤¤¤Æ°ìÄê¤Î´ÉÍýµÁ̳¤¬¤¢¤ë¤³¤È¤â³Îǧ¤µ¤ì¤¿¡£

Á´4¥Ú¡¼¥¸

[1] [2] [3] [4]

[ ¼¡¤Î¥Ú¡¼¥¸ ]


¤è¤·¤â¤È¥Ö¥í¥°¥é¥ó¥­¥ó¥°

¤â¤Ã¤È¸«¤ë

[PR]¤ªÆÀ¾ðÊó

ÏÃÂê¤Î¿·¾¦Éʤ¬º£¤À¤±¤â¤é¤¨¤ë¡ª
¥¸¥å¥ì¡¼¥à¥¢¥ß¥Î¡¡¥·¥å¡¼¥×¥ê¡¼¥à
¥×¥ì¥¼¥ó¥È¥­¥ã¥ó¥Ú¡¼¥ó
¤Õ¤ë¤µ¤ÈǼÀÇ¥µ¥¤¥È¡Ø¤µ¤È¤Õ¤ë¡Ù
11¡¿30¤Þ¤Ç£µ¼þǯµ­Ç°¥­¥ã¥ó¥Ú¡¼¥óÃæ¡ª
Amazon¥®¥Õ¥È·ô1000±ßʬÅö¤¿¤ë¡ª
¤ªÆù¡¢µû²ð¡¢¤ªÊÆ¡¢¤ª¤»¤Á¤Þ¤Ç
¤ª¤¹¤¹¤áÆÃ»ºÉʤ¬¥é¥ó¥­¥ó¥°¤ÇÁª¤Ù¤ë
¤Õ¤ë¤µ¤ÈǼÀÇ¥µ¥¤¥È¡Ø¤µ¤È¤Õ¤ë¡Ù
¥³¥ó¥¿¥¯¥È¥ì¥ó¥º¤Ç±ó¶áξÍÑ¡©
¡Ö2WEEK¥á¥Ë¥³¥ó¥×¥ì¥ß¥ª±ó¶áξÍÑ¡×
̵ÎÁ¥â¥Ë¥¿¡¼Êç½¸Ãæ¡ª

¤½¤Î¾¤Î¥­¥ã¥ó¥Ú¡¼¥ó


¤ß¤ó¤Ê¤Î¹¹¿·µ­»ö